Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/92114
Title: Estimated prevalence of harmful alcohol consumption in pregnant and nonpregnant women in Saxony-Anhalt (NorthEast Germany) using biomarkers
Author(s): Adler, JakobLook up in the Integrated Authority File of the German National Library
Rißmann, AnkeLook up in the Integrated Authority File of the German National Library
Kropf, Siegfried
Mohnike, KlausLook up in the Integrated Authority File of the German National Library
Taneva, Elina
Ansorge, Thomas
Zenker, MartinLook up in the Integrated Authority File of the German National Library
Wex, ThomasLook up in the Integrated Authority File of the German National Library
Issue Date: 2021
Type: Article
Language: English
URN: urn:nbn:de:gbv:ma9:1-1981185920-940663
Subjects: Alcohol
Pregnancy
Prevalence
%CDT
GGT
GGT-CDT Ratio
Abstract: Background: Alcohol consumption is commonly accepted in Western societies and is a known risk factor in pregnancy, which could lead to fetal alcohol spectrum disorders (FASDs). Prevalence of alcohol consumption during pregnancy is mostly unknown. Prevalence estimates in publications based on questionnaires are limited by possible underreporting due to social stigmatization. The aim of this study was to estimate the prevalence of harmful alcohol consumption in a large cohort of pregnant women using different biomarkers related to alcohol consumption and compare the findings with those of nonpregnant women Methods: Routine parameters known to be influenced by alcohol consumption (c-glutamyltransferase, GGT; carbohydrate-deficient transferrin, CDT/%CDT; mean corpuscular/cell volume, MCV; combined parameter of GGT and %CDT, GGT-CDT) were analyzed in serum samples of 2,182 pregnant women and 743 non-pregnant, age-matched females. Data were tested for (i) differences between pregnant and non-pregnant women and (ii) changes across the 3 trimesters of pregnancy. Results: Prevalence rates differ greatly according to the parameter and cutoff, which reflects the limitations of assessing alcohol consumption with biomarkers. The prevalence of harmful alcohol consumption on the basis of a single or several elevated parameters was 13.8% (95% CI: 12.4 to 15.2) in pregnant women and 18.6% (95% CI: 15.8 to 21.4) in non-pregnant women, though 85.0% of the elevated measurements were attributable to an isolated elevation in %CDT only. Using GGT-CDT as the parameter with the highest specificity according to the literature, the estimated prevalence of harmful alcohol consumption in pregnancy is 0.5% (95% CI: 0.2 to 0.7). Conclusion: Estimated prevalence rates differ greatly with respect to the biomarkers and cutoffs used. The use of CDT/%CDT alone appears to overestimate harmful alcohol consumption during pregnancy.
URI: https://opendata.uni-halle.de//handle/1981185920/94066
http://dx.doi.org/10.25673/92114
Open Access: Open access publication
License: (CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0(CC BY-NC-ND 4.0) Creative Commons Attribution NonCommercial NoDerivatives 4.0
Sponsor/Funder: Projekt DEAL 2021
Journal Title: Alcoholism
Publisher: Wiley-Blackwell
Publisher Place: Oxford [u.a.]
Volume: 45
Issue: 4
Original Publication: 10.1111/acer.14567
Page Start: 819
Page End: 827
Appears in Collections:Medizinische Fakultät (OA)

Files in This Item:
File Description SizeFormat 
Adler et al._Estimated prevalence_2022.pdfZweitveröffentlichung454.3 kBAdobe PDFThumbnail
View/Open